
Ibuprofen diethylaminoethyl ester
CAS No. 64622-41-9
Ibuprofen diethylaminoethyl ester( —— )
Catalog No. M34279 CAS No. 64622-41-9
Ibuprofen diethylaminoethyl ester (BF DEAE) has anti-inflammatory activity, acts as a local anaesthetic and can be used in the study of neurological disorders.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 445 | Get Quote |
![]() ![]() |
5MG | 686 | Get Quote |
![]() ![]() |
10MG | 938 | Get Quote |
![]() ![]() |
25MG | 1398 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameIbuprofen diethylaminoethyl ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionIbuprofen diethylaminoethyl ester (BF DEAE) has anti-inflammatory activity, acts as a local anaesthetic and can be used in the study of neurological disorders.
-
DescriptionIbuprofen diethylaminoethyl ester (BF DEAE) has anti-inflammatory activity, acts as a local anaesthetic and can be used in the study of neurological disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64622-41-9
-
Formula Weight305.45
-
Molecular FormulaC19H31NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCCN(CC)CC)C(C1=CC=C(C=C1)CC(C)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
LDC-4297 HCl
LDC4297 is a potent and selective CDK7 inhibitor with an IC50 of 0.13 nM.
-
NCGC00135472
NCGC00135472 (DRV1 (GPR32) agonist C2A) is a human Resolvin DI receptor DRV1 agonist with pro-catabolic properties that activates the human soluble protein D1 receptor DRV1/GPR32 receptor in beta-blocker and cAMP assays with EC50s of 0.37 uM and 0.05 uM, respectively.
-
PA-8
PA-8 is a small molecule receptor antagonist for PACAP Type I (PAC1) that is selective, effective, and orally active. PA-8 inhibits PacAP-induced CREB phosphorylation at PAC1- receptors, but does not inhibit VPAC1- or vpac2 receptors.